- Home
- HUDI vs IBIO Comparison
HUDI vs IBIO Comparison
Compare HUDI & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HUDI | IBIO |
|---|---|---|
| Founded | 1998 | 2008 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.1M | 16.4M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | HUDI | IBIO |
|---|---|---|
| Price | $1.16 | $1.89 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 13.5K | ★ 13.3M |
| Earning Date | 01-29-2026 | 02-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $66,566,370.00 | $500,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $11.11 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 185.71 |
| 52 Week Low | $1.06 | $0.56 |
| 52 Week High | $5.46 | $6.89 |
Technical Indicators
Market Signals| Indicator | HUDI | IBIO |
|---|---|---|
| Relative Strength Index (RSI) | 39.19 | 54.62 |
| Support Level | $1.16 | $1.86 |
| Resistance Level | $1.34 | $2.14 |
| Average True Range (ATR) | 0.07 | 0.44 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 0.00 | 14.69 |
Price Performance
Historical ComparisonAbout HUDI Huadi International Group Co. Ltd.
Huadi International Group Co Ltd is a manufacturer of industrial stainless steel seamless pipes and tubes products. Its products are used in the oil & gas transmission, chemistry engineering, food processing, medical devices, aeronautics and astronautics, boiler, irrigation works construction, automobile and naval architecture, paper mill and mechanical industries. Company generates revenue from Sales of steel piping products. Products are exported to the United States, Mexico, Thailand, Singapore, Argentina, Taiwan, India, the Philippines, UAE and Canada. Geographically, majority revenue is generated from China.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.